# A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

> **NCT07392372** · PHASE1 · RECRUITING · sponsor: **BioNTech SE** · enrollment: 61 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **DRUG:** BNT351
- **DRUG:** Placebo
- **DRUG:** BNT351
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07392372
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07392372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07392372, "A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07392372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*